Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 24 Weeks, Multicenter, Randomized, Double-blind, Placebo, Parallel-controlled Phase IIb Trail Comparing the Efficacy and Safety of MDR-001 Tablet Versus Placebo in Subjects With Overweight or Obesity

NCT06606483 is registered in ClinicalTrials.gov with MindRank AI Ltd as lead sponsor.

NCT NCT06606483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06606483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 24 Weeks, Multicenter, Randomized, Double-blind, Placebo, Parallel-controlled Phase IIb Trail Comparing the Efficacy and Safety of MDR-001 Tablet Versus Placebo in Subjects With Overweight or Obesity
Lead sponsor
MindRank AI Ltd
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 23, 2024
Completion date
September 30, 2025
Enrollment
300 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight and obesity